Publications by authors named "T Olencki"

Claim this Profile
A
Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis development.
Mark Damante, Kristin Huntoon, David Gibbs, Dante Pezzutti, Thomas Olencki

Neurosurg Focus· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.
Shaheer Khan, Jose Lutzky, Alexander N Shoushtari, Joanne Jeter, Brian Marr, Thomas E Olencki

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapy.
Kristin Huntoon, Mark Damante, Joshua Wang, Thomas Olencki, J Bradley Elder

Curr Probl Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
Paul Nghiem, Shailender Bhatia, Evan J Lipson, William H Sharfman, Ragini R Kudchadkar, Thomas Olencki

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Moshe C Ornstein, Sumanta K Pal, Laura S Wood, Jackie M Tomer, Brian P Hobbs, Thomas Olencki

Lancet Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis